Development and characterization of a tamoxifen-resistant breast carcinoma xenograft
Open Access
- 5 May 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (11) , 1844-1850
- https://doi.org/10.1054/bjoc.2000.1156
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Human breast cancer cell line xenografts as models of breast cancer — The immunobiologies of recipient mice and the characteristics of several tumorigenic cell linesBreast Cancer Research and Treatment, 1996
- Mechanisms of Tamoxifen Resistance in the Treatment of Advanced Breast CancerActa Oncologica, 1996
- Possible mechanisms in the emergence of tamoxifen-resistant breast cancerAnti-Cancer Drugs, 1995
- The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cellsClinical & Experimental Metastasis, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Establishment and characterization of a new human oestradiol- and progesterone-receptor-positive mammary carcinoma serially transplantable in nude miceZeitschrift für Krebsforschung und Klinische Onkologie, 1992
- Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapyEuropean Journal of Cancer and Clinical Oncology, 1987
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- A secreted glycoprotein induced by estrogen in human breast cancer cell linesCell, 1980